TY - JOUR
T1 - The Role of a Novel Long Noncoding RNA TUC40- in Cardiomyocyte Induction and Maturation in P19 Cells
AU - Li, Huijuan
AU - Jiang, Li
AU - Yu, Zhangbin
AU - Han, Shuping
AU - Liu, Xuehua
AU - Li, Mengmeng
AU - Zhu, Chun
AU - Qiao, Lixing
AU - Huang, Li
N1 - Funding Information:
This work was supported by Grants from the National Natural Science Foundation of China, China (Grant no. 81470376), the Natural Science Foundation of Jiangsu Province, China (Grant no. BK20141077), the Medical Youth Personnel Foundation of Nanjing Municipality (Grant no. QRX11107), Nanjing Municipal Medical Science Development Foundation (YKK14123).
Publisher Copyright:
© 2017 Southern Society for Clinical Investigation
PY - 2017/12
Y1 - 2017/12
N2 - Background: In previous studies, TUC40-, a new long noncoding RNA, was found to be overexpressed in human ventricular septal defect (VSD) embryonic heart samples. In this article, we carried out experiments on the P19 cell line to elucidate the effects of TUC40- overexpression on cardiomyocyte development relevant to VSD pathogenesis. Methods: We established the overexpression cell model by plasmid transfection, and explored the expression profile of Pbx1, the sense gene of TUC40-, and the marker genes of cardiomyocyte linage commitment (Nkx2.5 and GATA4) and maturation (cardiac troponin T). In addition, we combined cell cycle and Cell Counting Kit-8 analysis to detect cell proliferation and used flow cytometry and caspase-3 assays to test apoptosis. At last, bioinformatics analysis was performed to show the possible role of TUC40-. Results: In the control group, Pbx1 elevated steadily during cardiomyocyte induction; whereas in the overexpression group, it showed significantly lower expression at day 6, 8 and 10 of induction. Cells in the overexpression group failed to induce cardiomyocytes indicated by GATA4 and cardiac troponin T. Proliferation was inhibited possibly owing to G2/M cell cycle arrest and the induced apoptosis rate was higher in the overexpression group. Conclusions: TUC40- overexpression reduced Pbx1 expression, cardiomyocyte induction and differentiation, inhibited proliferation and promoted apoptosis. Combining the results and previous studies, we propose TUC40- as a potential pathologic factor for VSD.
AB - Background: In previous studies, TUC40-, a new long noncoding RNA, was found to be overexpressed in human ventricular septal defect (VSD) embryonic heart samples. In this article, we carried out experiments on the P19 cell line to elucidate the effects of TUC40- overexpression on cardiomyocyte development relevant to VSD pathogenesis. Methods: We established the overexpression cell model by plasmid transfection, and explored the expression profile of Pbx1, the sense gene of TUC40-, and the marker genes of cardiomyocyte linage commitment (Nkx2.5 and GATA4) and maturation (cardiac troponin T). In addition, we combined cell cycle and Cell Counting Kit-8 analysis to detect cell proliferation and used flow cytometry and caspase-3 assays to test apoptosis. At last, bioinformatics analysis was performed to show the possible role of TUC40-. Results: In the control group, Pbx1 elevated steadily during cardiomyocyte induction; whereas in the overexpression group, it showed significantly lower expression at day 6, 8 and 10 of induction. Cells in the overexpression group failed to induce cardiomyocytes indicated by GATA4 and cardiac troponin T. Proliferation was inhibited possibly owing to G2/M cell cycle arrest and the induced apoptosis rate was higher in the overexpression group. Conclusions: TUC40- overexpression reduced Pbx1 expression, cardiomyocyte induction and differentiation, inhibited proliferation and promoted apoptosis. Combining the results and previous studies, we propose TUC40- as a potential pathologic factor for VSD.
KW - Cardiomyocyte
KW - Long noncoding RNA
KW - Pbx1
KW - TUC40-
KW - Ventricular septal defect
UR - http://www.scopus.com/inward/record.url?scp=85038130169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038130169&partnerID=8YFLogxK
U2 - 10.1016/j.amjms.2017.08.019
DO - 10.1016/j.amjms.2017.08.019
M3 - Article
C2 - 29208259
AN - SCOPUS:85038130169
SN - 0002-9629
VL - 354
SP - 608
EP - 616
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 6
ER -